Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,063 results for ""Xenograft Model Antitumor Assays""

Your Filters

Subject : drug delivery systems
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Folic Acid-Functionalized β-Cyclodextrin for Delivery of Organelle-Targeted Peptide Chemotherapeutics in Cancer.

  • Authors : Ok HW; Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea.; Jin S

Subjects: Folic Acid*/Folic Acid*/Folic Acid*/chemistry ; beta-Cyclodextrins*/beta-Cyclodextrins*/beta-Cyclodextrins*/chemistry ; Drug Delivery Systems*/Drug Delivery Systems*/Drug Delivery Systems*/methods

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 Sep 02; Vol. 21 (9), pp. 4498-4509. Date of Electronic Publication: 2024 Jul 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery by Somatostatin Analog.

  • Authors : Gu X; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08554, USA.; Majumder J

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/metabolism ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 19; Vol. 25 (10). Date of Electronic Publication: 2024 May 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Nuclear-targeted p53 and DOX co-delivery of chitosan derivatives for cancer therapy in vitro and in vivo.

  • Authors : Lin JT; Dongguan Research Center of Guangdong Medical University, Guangdong Medical University, Dongguan 523808, China; Department of Pharmacy, Songgang People's Hospital, Shenzhen, 518105, China. Electronic address: .

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Cell Nucleus/Cell Nucleus/Cell Nucleus/*metabolism

  • Source: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2019 Nov 01; Vol. 183, pp. 110440. Date of Electronic Publication: 2019 Aug 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.

  • Authors : Yang T; Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, No. 1160, Shengli Street, Yinchuan, 750004, China.; Lan Y

Subjects: Micelles* ; Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology

  • Source: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2019 Mar 01; Vol. 175, pp. 106-115. Date of Electronic Publication: 2018 Nov 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer.

  • Authors : Bouzo BL; Nano-Oncology and Translational Therapeutics Unit, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, CIBERONC, 15706, Santiago de Compostela, Spain.; Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela (USC), Av. Barcelona s/n Campus Vida, 15706, Santiago de Compostela, Spain.

Subjects: Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy ; Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*methods ; Etoposide/Etoposide/Etoposide/*administration & dosage

  • Source: Scientific reports [Sci Rep] 2021 Aug 26; Vol. 11 (1), pp. 17213. Date of Electronic Publication: 2021 Aug 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Non-toxic polymer nanovectors for improved delivery of dexamethasone.

  • Authors : Ede BC; School of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol, BS8 1TD, UK.; Diamanti P

Subjects: Dexamethasone/Dexamethasone/Dexamethasone/*administration & dosage ; Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*methods ; Nanostructures/Nanostructures/Nanostructures/*chemistry

  • Source: Scientific reports [Sci Rep] 2021 Aug 26; Vol. 11 (1), pp. 17263. Date of Electronic Publication: 2021 Aug 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.

  • Authors : Sayyed AA; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Gujarat 382355, India.; Gondaliya P

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Cisplatin/Cisplatin/Cisplatin/*administration & dosage ; Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*methods

  • Source: Molecular pharmaceutics [Mol Pharm] 2021 Aug 02; Vol. 18 (8), pp. 3010-3025. Date of Electronic Publication: 2021 Jun 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma.

  • Authors : Sagnella SM; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Australian Centre for NanoMedicine, University of New South Wales Sydney, New South Wales, Australia.

Subjects: Xenograft Model Antitumor Assays*; Doxorubicin/Doxorubicin/Doxorubicin/*administration & dosage ; Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*methods

  • Source: Molecular cancer therapeutics [Mol Cancer Ther] 2018 May; Vol. 17 (5), pp. 1012-1023. Date of Electronic Publication: 2018 Feb 28.Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.

  • Authors : Xie Z; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China.; Guo W

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/chemistry ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacokinetics ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Acta biomaterialia [Acta Biomater] 2018 Apr 15; Vol. 71, pp. 351-362. Date of Electronic Publication: 2018 Mar 13.Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.

  • Authors : Matsumoto T; Bioscience and Engineering laboratories, FUJIFILM Corporation, 577 Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan. .; Komori T

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*blood ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Drug Compounding/Drug Compounding/Drug Compounding/*methods

  • Source: Pharmaceutical research [Pharm Res] 2021 Jun; Vol. 38 (6), pp. 1093-1106. Date of Electronic Publication: 2021 May 07.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,063 results for ""Xenograft Model Antitumor Assays""